Inventor

KUAN CHIEN-TSUN

US20 patents

⚠️ This page may combine multiple inventors who share the name “KUAN CHIEN-TSUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KUAN CHIEN-TSUN

UNIV DUKE

Antibodies and immunotoxins that target human glycoprotein NMB

Dual specific immunotoxin for brain tumor therapy

Human bispecific EGFRvIII and CD3 antibody engaging molecules

Dual specific immunotoxin for brain tumor therapy

Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides

Human bispecific EGFRvIII antibody and CD3 engaging molecules

UNIV JOHNS HOPKINS

Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma

Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma

Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma

Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma

US HEALTH

Nucleic acids encoding immunotoxins containing a disulfide-stabilized antibody fragment replacing half or more of domain IB of pseudomonas exotoxin, and methods of use of the encoded immunotoxins

Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation

Antibodies and immunotoxins that target human glycoprotein NMB

KUAN CHIEN-TSUN

Antibodies and immunotoxins that target human glycoprotein NMB

Anti-MRP3 antibodies and methods of use

DEV CT BIOTECHNOLOGY

Anti-human TIM-3 antibodies and methods of use thereof

Anti-VEGFR antibody and uses thereof

VOGELSTEIN BERT

Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma

BIGNER DARELL D

Bispecific EGFRvIII x CD3 antibody engaging molecules

BIGNER DARELL

Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides